Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Is Celgene Stock Still Worth Holding Onto in the Long Run?

By Chris Lau, InvestorPlace Contributor

Celgene and Bristol-Myers got the green light from shareholders to move forward on the deal. More upside awaits for CELG stock.

5 Automobile Stocks to Consider Now

By Chris Lau, InvestorPlace Contributor

Many automobile stocks are dirt cheap right now, but in the bigger picture, some are better than others. Here are five to keep an eye on.

Here’s Why Walmart Stock Can’t Seem to Break Out Above $100

By Chris Lau, InvestorPlace Contributor

Walmart shares are not exactly cheap but that is not the main reason WMT stock stalls whenever it gets close to the $100 level.

Why General Electric Stock Shouldn’t Trade Much Below $10

By Chris Lau, InvestorPlace Contributor

General Electric stock can make money for investors who hold GE stock for at least a couple of years, since its CEO can execute a turnaround.

Southwest Airlines Stock Will Bottom Out Very Soon

By Chris Lau, InvestorPlace Contributor

High oil prices and worries over Boeing's MAX 737 are hurting Southwest Airlines stock. Markets forget its value from running at low cost.

Load More